Neurodegenerative diseases distinguished through protein-structure analysis
暂无分享,去创建一个
[1] K. Nilsson,et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy , 2020, Nature.
[2] R. Riek,et al. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy , 2019, eLife.
[3] G. Halliday,et al. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts , 2019, Nature Communications.
[4] Raphaella W. L. So,et al. α-Synuclein Strains Target Distinct Brain Regions and Cell Types , 2019, Nature Neuroscience.
[5] A. Murzin,et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases , 2018, bioRxiv.
[6] John L. Robinson,et al. Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies , 2018, Nature.
[7] J. Collinge. Mammalian prions and their wider relevance in neurodegenerative diseases , 2016, Nature.
[8] Charles D. Schwieters,et al. Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.
[9] C. Weissmann. Mutation and Selection of Prions , 2012, PLoS pathogens.
[10] Jie Li,et al. Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .